Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
29.69B | 29.93B | 28.54B | 30.17B | 32.37B | 32.06B | Gross Profit |
4.87B | 5.49B | 4.58B | 4.00B | 6.32B | 7.22B | EBIT |
1.33B | 1.89B | 1.07B | 451.06M | 2.71B | 4.02B | EBITDA |
3.05B | 3.46B | 2.60B | 1.95B | 4.25B | 5.16B | Net Income Common Stockholders |
1.04B | 1.48B | 820.48M | 310.65M | 2.06B | 2.62B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.12B | 1.18B | 972.01M | 853.40M | 718.63M | 830.35M | Total Assets |
29.67B | 30.41B | 29.72B | 31.07B | 32.42B | 27.96B | Total Debt |
1.65B | 1.49B | 2.21B | 4.33B | 808.15M | 555.36M | Net Debt |
526.00M | 308.00M | 1.24B | 3.48B | 89.52M | -275.00M | Total Liabilities |
11.65B | 11.91B | 12.51B | 14.50B | 15.67B | 12.72B | Stockholders Equity |
18.02B | 18.50B | 17.21B | 16.57B | 16.75B | 15.24B |
Cash Flow | Free Cash Flow | ||||
0.00 | 2.97B | 2.49B | -2.85B | -3.41B | 3.16B | Operating Cash Flow |
0.00 | 4.37B | 3.63B | 1.48B | -1.33B | 5.22B | Investing Cash Flow |
0.00 | -1.42B | -1.14B | -4.34B | -2.08B | -2.09B | Financing Cash Flow |
0.00 | -997.00M | -2.39B | 3.00B | -273.53M | -680.45M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥17.70B | 11.97 | 3.56% | 4.85% | 80.14% | ||
75 Outperform | ¥15.84B | 7.09 | 4.75% | 12.71% | 123.51% | ||
72 Outperform | ¥15.40B | 9.84 | 2.77% | 5.96% | 182.60% | ||
72 Outperform | ¥17.96B | 11.71 | 3.93% | 10.43% | 187.34% | ||
71 Outperform | ¥18.69B | 9.74 | 3.55% | 0.78% | -5.93% | ||
69 Neutral | ¥17.52B | 6.85 | 4.62% | 0.79% | 61.23% | ||
51 Neutral | $2.03B | -1.27 | -21.09% | 3.98% | 2.91% | -30.50% |
Taoka Chemical Co., Ltd. announced an increase in its year-end dividend per share from the forecasted ¥18.00 to ¥22.00, based on strong financial results for the fiscal year ended March 31, 2025. This decision reflects the company’s robust financial performance and commitment to returning value to shareholders, with the total dividends amounting to ¥315 million, sourced from retained earnings.
Taoka Chemical Co., Ltd. reported a significant improvement in its financial performance for the fiscal year ended March 31, 2025, with notable increases in net sales and profits. The company achieved a 4.9% increase in net sales and substantial growth in operating and ordinary profits, indicating a strong recovery from the previous year’s decline. This financial upswing reflects positively on the company’s operational efficiency and market positioning, potentially enhancing stakeholder confidence.
Taoka Chemical Co., Ltd. reported a significant improvement in its financial performance for the fiscal year ending March 2025. The company achieved a 4.9% increase in net sales and a substantial rise in operating profit by 75.6%, indicating a strong recovery from the previous year’s decline. This growth reflects positively on the company’s operational efficiency and market positioning, potentially benefiting stakeholders through increased profitability and shareholder value.